Citadel Advisors’s Jin Medical International ZJYL Stock Holding History

Citadel Advisors’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,890	Closed	-$25.9K	–	14425
2025 Q4	$25.9K	Buy	+5,890	New	+$34.7K	﹤0.01%	12271
2025 Q3	–	Sell	-6,506	Closed	-$83.8K	–	14328
2025 Q2	$83.8K	Buy	+6,506	New	+$99.1K	﹤0.01%	11461

Other funds holding ZJYL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's ZJYL Position: Q1 2026 in Review

Citadel Advisors sold out of Jin Medical International (ZJYL) in Q1 2026, closing a stake of 5,890 shares — an estimated $25.9K sold.

Citadel Advisors first reported a position in ZJYL in Q2 2025 and held it in 2 quarters. The position peaked at $83.8K in Q2 2025. 2 funds tracked by Wall St. Rank hold ZJYL as of Q1 2026.

Citadel Advisors reported no remaining Jin Medical International position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 5,890 Jin Medical International shares in Q1 2026, an estimated $25.9K.
Citadel Advisors first reported a position in Jin Medical International in Q2 2025 and held it in 2 quarters.
Citadel Advisors's Jin Medical International position peaked at $83.8K in Q2 2025.
2 funds tracked by Wall St. Rank held Jin Medical International as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.